- Home
- SNEX vs RVNC Comparison
SNEX vs RVNC Comparison
Compare SNEX & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNEX
- RVNC
- Stock Information
- Founded
- SNEX 1924
- RVNC 1999
- Country
- SNEX United States
- RVNC United States
- Employees
- SNEX N/A
- RVNC N/A
- Industry
- SNEX Investment Bankers/Brokers/Service
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- SNEX Finance
- RVNC Health Care
- Exchange
- SNEX Nasdaq
- RVNC Nasdaq
- Market Cap
- SNEX 3.1B
- RVNC 320.5M
- IPO Year
- SNEX 1994
- RVNC 2014
- Fundamental
- Price
- SNEX $99.01
- RVNC $3.07
- Analyst Decision
- SNEX
- RVNC Hold
- Analyst Count
- SNEX 0
- RVNC 9
- Target Price
- SNEX N/A
- RVNC $7.78
- AVG Volume (30 Days)
- SNEX 175.2K
- RVNC 3.4M
- Earning Date
- SNEX 02-04-2025
- RVNC 02-26-2025
- Dividend Yield
- SNEX N/A
- RVNC N/A
- EPS Growth
- SNEX 6.85
- RVNC N/A
- EPS
- SNEX 7.96
- RVNC N/A
- Revenue
- SNEX $98,704,300,000.00
- RVNC $256,945,000.00
- Revenue This Year
- SNEX N/A
- RVNC $11.28
- Revenue Next Year
- SNEX N/A
- RVNC $27.21
- P/E Ratio
- SNEX $12.45
- RVNC N/A
- Revenue Growth
- SNEX 64.52
- RVNC 25.82
- 52 Week Low
- SNEX $61.68
- RVNC $2.30
- 52 Week High
- SNEX $106.77
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- SNEX 49.32
- RVNC 33.02
- Support Level
- SNEX $95.46
- RVNC $3.06
- Resistance Level
- SNEX $100.56
- RVNC $3.09
- Average True Range (ATR)
- SNEX 2.65
- RVNC 0.02
- MACD
- SNEX -0.30
- RVNC 0.05
- Stochastic Oscillator
- SNEX 55.86
- RVNC 44.44
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.